Eli Lilly climbs after disclosing additional details on SARS-CoV-2 neutralizing antibody programs Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Eli Lilly (LLY) up 3% after announcing additional details on its SARS-CoV-2 neutralizing antibody programs including interim data on combination therapy in recently diagnosed patients with mild-to-moderate COVID-19 and plans to make these therapies broadly available to patients
- JetBlue (JBLU) up 6% after JPMorgan analyst Jamie Baker double upgraded the stock to Overweight from Underweight with a price target of $17, up from $12
- Perion Network (PERI) up 12% after raising its FY20 revenue view
- American Eagle (AEO) up 5% after Barclays analyst Adrienne Yih upgraded shares to Overweight from Equal Weight with an $18 price target
- Coty (COTY) up 4% after
Jefferies analyst Stephanie Wissink upgraded the stock to Buy from Hold with an unchanged price target of $4
UP AFTER EARNINGS -
- RPM (RPM) up 2%
- Levi Strauss (LEVI) up 12%
LOWER -
- DraftKings (DKNG) down 8% after its 32M share secondary offering priced at $52.00 per share
- Bandwidth (BAND) down 4% after Morgan Stanley analyst Meta Marshall downgraded shares to Underweight from Equal Weight with a price target of $140, up from $120
- CleanSpark (CLSK) down 18% after its 4.4M share spot secondary offering priced at $9.00
Symbols:
LLY JBLU PERI AEO COTY RPM LEVI DKNG CLSK BAND - $184.81 /
+3.285 (+1.81%)
Keywords: Fly Intel, Wall Street, Top Stories, Stocks